News

Anatomy of a molecule:
What makes remdesivir unique?

Experts weigh in on the chemistry of the potential SARS-nCoV-2 antiviral
Laurel Oldach
March 17, 2020

The World Health Organization in late January convened experts to discuss experimental therapeutics for patients with the emerging coronavirus with no name, no vaccine and no treatment. The panel reported that “among the different therapeutic options, remdesivir was considered the most promising candidate.”

Within weeks, a clinical trial of the compound was underway in China. Results are expected in April; in the meantime, the outbreak of SARS-nCoV-2, the virus that causes COVID-19, has become a global pandemic.

Remdesivir is a nucleoside analog, one of the oldest classes of antiviral drugs. It works by blocking the RNA polymerase that coronaviruses and related RNA viruses need to replicate their genomes and proliferate in the host body.

The molecule originally was synthesized as part of a screen for inhibitors of the hepatitis C virus RNA polymerase. Its inventors at Gilead Sciences decided to move forward with a different nucleoside analog compound to treat hepatitis C. But RNA-dependent RNA polymerases are conserved between many viruses. Experiments in vitro, in cell culture and in animal models have shown that remdesivir has broad-spectrum activity against RNA viruses, including filoviruses (like the one that causes Ebola) and coronaviruses.

Remdesivir resembles the RNA base adenosine, shown here as a monophosphate.

AMP.jpg

The compound and ATP have some important differences, but some features are very similar. ASBMB Today spoke to medicinal chemist Katherine Seley–Radtke at the University of Maryland, Baltimore County, and structural virologist Craig Cameron at the University of North Carolina, Chapel Hill about what makes the molecule interesting. Click on a feature marked in blue to read their remarks.

Laurel Oldach

Laurel Oldach is a science writer for the ASBMB.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

More than skin-deep
Journal News

More than skin-deep

June 02, 2020

Researchers in Korea have found a novel bacterial lipase structure that may lead to new treatments for acne.

Alzheimer’s & Brain Awareness Month 2020
Health Observance

Alzheimer’s & Brain Awareness Month 2020

June 01, 2020

Every June, the Alzheimer's Association raises awareness of this neurodegenerative disease during the Alzheimer’s & Brain Awareness Month. Here, contributor Adriana Bankston highlights recent Alzheimer's research.

How long can viruses survive in a dead body?
News

How long can viruses survive in a dead body?

May 31, 2020

A Q&A with Matt Koci, a virologist and immunologist at North Carolina State University.

Could gut microbes be key to solving food allergies?
News

Could gut microbes be key to solving food allergies?

May 30, 2020

New therapeutics are testing whether protective bacteria can dampen harmful immune responses to food.

From the journals: JBC
Journal News

From the journals: JBC

May 28, 2020

Enzymes playing hot potato with heme. A CRISPR system that cuts indiscriminately. Cholesterol levels changing ATP signaling. Read about recent papers on these topics and more in the Journal of Biological Chemistry.

How to catch and kill a coronavirus on a doorknob
News

How to catch and kill a coronavirus on a doorknob

May 27, 2020

Researchers at Miami University are developing polymer coatings to inactivate SARS-CoV-2 on public surfaces.